Phase 1b data shows treatment with SAT-3247 was safe and well-tolerated Pharmacokinetic (PK) profile of SAT-3247 translated as expected to Duchenne Muscular Dystrophy (DMD) patients taking concurrent ...
Actinogen Medical Limited (ASX: ACW) announces that the first participant has been treated in the open-label extension (OLE) ...
(RTTNews) - Greenwich LifeSciences, Inc. (GLSI), a clinical-stage biopharmaceutical company, on Monday announced a preliminary update from its open-label analysis of HLA data in the ongoing Phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results